查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1949551

活細胞成像市場－全球產業規模、佔有率、趨勢、機會及預測（按產品、應用、技術、最終用戶、地區和競爭格局分類，2021-2031年）

Live Cell Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Technology, By End-Users, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球活細胞成像市場預計將從 2025 年的 32.2 億美元成長到 2031 年的 53.5 億美元，複合年成長率為 8.83%。

這項技術透過延時顯微鏡技術，能夠視覺化活體樣本內部的細胞結構和動態過程，實現即時生物學分析。該市場的主要成長要素是慢性病發病率的上升以及由此帶來的藥物研發中對高內涵篩檢的需求。根據美國癌症協會預測，到2024年，美國預計將新增約200萬例癌症病例，因此需要對細胞研究和開發進行大量投資。

市場概覽
預測期 2027-2031
市場規模：2025年 32.2億美元
市場規模：2031年 53.5億美元
複合年成長率：2026-2031年 8.83%
成長最快的細分市場 延時顯微鏡
最大的市場 北美洲

然而，市場擴張面臨一個重大障礙：高解析度儀器需要大量的資本投入。這些高昂的成本阻礙了預算有限的小規模學術機構和生物技術公司採用這些儀器。此外，在顯微鏡載物台上維持生理條件以避免光毒性的技術複雜性也帶來了操作上的挑戰。這些困難使得長期實驗難以進行，並阻礙了這些先進成像方法的廣泛應用。

市場促進因素

將人工智慧 (AI) 和機器學習技術整合到影像分析軟體中，是推動市場發展的重要因素，從根本上改變了細胞​​數據的解讀方式。這些計算工具能夠自動完成細胞分割和追蹤，使研究人員能夠以最少的人工干預從海量圖像資料集中提取有意義的動態數據。這項技術進步對於降低光毒性至關重要，而人工智慧增強的修復演算法能夠減少影像擷取過程中的光照，從而在長期縱向研究中保持細胞活力。為了反映其在該領域的投入規模，諾和諾德基金會在2024年3月的「Gefion 推出」活動上承諾捐贈約6億丹麥克朗，用於資助一台旨在加速細胞生物學和藥物研發的新型人工智慧超級電腦。

同時，生命科學研究經費和私人投資的不斷成長正推動先進顯微鏡系統在藥物研發領域的應用。製藥公司優先考慮高內涵篩檢以識別治療靶點，並需要強大的成像基礎設施來支援即時動態分析。這筆資金的湧入支持了能夠進行高通量處理的自動化活細胞平台的採購。根據羅氏公司於2024年3月發布的《2023年度報告》，該集團已投資132億瑞士法郎用於研發，以加強其多元化的診斷和治療產品組合。此外，公共部門的支持仍然是市場穩定的關鍵支柱。根據美國科學促進會（AAAS）於2024年3月發布的《2024年最終預算》更新報告，美國國立衛生研究院（NIH）共獲得471億美元的專案級資金，用於支持生物醫學研究。

市場挑戰

高解析度設備需要大量的資金投入，這是全球市場的一個主要阻礙因素。先進的活細胞影像系統前期成本高昂，設定了很高的進入門檻，尤其對於中小型生物技術公司和學術機構更是如此。這些機構通常預算有限，難以購買高性能顯微鏡平台。有限的資金迫使潛在買家推遲設備升級或繼續使用過時的系統，這直接限制了製造商的銷售量，並阻礙了其在成本敏感型細分市場的滲透。

科研基礎設施經費削減進一步加劇了這種經濟壓力。根據美國科學促進會 (AAAS) 2024 年的一份報告，美國國立衛生研究院 (NIH) 的基本預算較上年度削減約 0.8%，這實際上降低了其購買科研設備的能力。這些聯邦資金限制迫使科學研究機構優先考慮必要的營運支出，而非購買新的資本資產。因此，高昂的設備擁有成本，加上難以獲得津貼，正在減緩成像技術的應用，並阻礙整體市場擴張。

市場趨勢

隨著研究人員越來越重視生理相關的微環境而非傳統的2D培養，向3D類器官和球狀體成像模型的轉變正在改變整個產業。這種轉變需要先進的顯微鏡解決方案，能夠進行深層組織穿透和長期體積監測，精確捕捉厚生物基質內動態的細胞間相互作用。業界正在積極回應，開發專用的高通量系統來支援這些複雜的工作流程，尤其是在腫瘤學和再生醫學領域。例如，賽多利斯公司在2024年2月發布的2023年度報告中顯示，其銷售額約為34億歐元，這充分體現了市場對支持先進細胞培養應用解決方案的強勁需求。

多體學與活細胞數據的整合是重大飛躍，推動市場從形態學觀察邁向全面的功能表現型分析。透過將即時成像與空間轉錄組學和蛋白​​質組學相結合，科學家現在可以繪製驅動細胞行為的分子機製圖譜。這項能力對於精準醫療和生物標記發現至關重要。這一趨勢正在推動結合光學顯微鏡和空間分析技術的混合平台的收購。為了佐證這項策略多元化帶來的財務影響，布魯克公司在2024年2月發布的「2023年第四季及全年業績報告」中報告稱，全年銷售額達29.6億美元，這主要得益於產品系列擴張。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球活細胞成像市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（設備、耗材、軟體、服務）
    • 依應用領域（細胞生物學、幹細胞、發育生物學、藥物發現）
    • 透過技術（延時顯微鏡、光漂白後螢光恢復、高內涵篩檢、螢光共振能量轉移等）
    • 依最終用戶（製藥/生技公司、學術/研究機構、合約研究組織）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美活細胞成像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲活細胞成像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區活細胞成像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲活細胞成像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲活細胞成像市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球活細胞影像市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies Inc.
  • Blue-Ray Biotech Corp.
  • Axion BioSystems, Inc
  • Curiosis Inc.
  • Carl Zeiss AG
  • Thermo Fisher Scientific Inc.
  • Perkin Elmer Inc
  • Danaher Corporation
  • Nikon Corporation

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 23943

The Global Live Cell Imaging Market is projected to expand from USD 3.22 Billion in 2025 to USD 5.35 Billion by 2031, reflecting a compound annual growth rate of 8.83%. This technology enables the visualization of internal cellular structures and dynamic processes within living specimens through time-lapse microscopy, thereby facilitating real-time biological analysis. The market is primarily driven by the increasing prevalence of chronic diseases and the consequent demand for high-content screening in pharmaceutical drug discovery. According to the American Cancer Society, approximately 2 million new cancer cases were expected to be diagnosed in the United States in 2024, necessitating substantial investment in cellular research and development.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.22 Billion
Market Size 2031USD 5.35 Billion
CAGR 2026-20318.83%
Fastest Growing SegmentTime Lapse Microscopy
Largest MarketNorth America

However, market expansion encounters a major obstacle due to the significant capital investment needed for high-resolution instrumentation. These steep costs limit accessibility for smaller academic institutions and biotechnology firms operating with restricted budgets. Furthermore, the technical complexity of maintaining physiological conditions on a microscope stage to avoid phototoxicity presents an operational challenge; this difficulty complicates long-term experimentation and hinders the wider adoption of these advanced imaging modalities.

Market Driver

The incorporation of artificial intelligence and machine learning into image analysis software serves as a primary market accelerator, fundamentally altering how cellular data is interpreted. These computational tools automate the segmentation and tracking of cells, allowing researchers to derive meaningful kinetic data from extensive image datasets with minimal manual effort. This technological advancement is crucial for reducing phototoxicity, as AI-enhanced restoration algorithms permit lower light exposure during image acquisition, thereby preserving cell viability for prolonged longitudinal studies. Illustrating the scale of commitment to this field, the Novo Nordisk Foundation announced in its 'Launch of Gefion' in March 2024 a pledge of approximately DKK 600 million for a new AI supercomputer designed to expedite discoveries in cell biology and drug development.

Concurrently, the increase in life science research funding and private investments is driving the adoption of advanced microscopy systems for drug discovery. Pharmaceutical companies are placing greater priority on high-content screening to identify therapeutic targets, requiring robust imaging infrastructure that supports real-time kinetic analysis. This influx of capital supports the procurement of automated live cell platforms capable of high-throughput processing. According to Roche's 'Annual Report 2023' released in March 2024, the group invested CHF 13.2 billion in research and development to strengthen its diverse diagnostics and therapeutics portfolio. Moreover, public sector support remains a vital pillar for market stability; the American Association for the Advancement of Science reported in its 'FY 2024 Final Appropriations' update in March 2024 that the National Institutes of Health received a total program level budget of USD 47.1 billion to support biomedical research.

Market Challenge

The necessity for substantial capital investment to acquire high-resolution instrumentation acts as a primary restraint on the global market. Advanced live cell imaging systems involve significant upfront costs that create high barriers to entry, particularly for smaller biotechnology companies and academic institutions. These organizations frequently operate within fixed fiscal boundaries, making the procurement of premium microscopy platforms challenging. When capital resources are scarce, potential buyers are often compelled to delay equipment upgrades or continue using legacy systems, which directly limits sales volume for manufacturers and restricts market penetration in cost-sensitive segments.

This economic strain is further exacerbated by reductions in support for scientific infrastructure. As reported by the American Association for the Advancement of Science in 2024, the base budget for the National Institutes of Health faced a reduction of approximately 0.8 percent compared to the previous fiscal year, effectively diminishing the purchasing power for research instrumentation. Such constraints on federal funding necessitate that research facilities prioritize essential operational expenses over new capital assets. Consequently, the high cost of ownership combined with reduced grant availability slows the adoption rate of imaging technologies and impedes overall market expansion.

Market Trends

The shift toward 3D Organoid and Spheroid Imaging Models is transforming the sector, as researchers increasingly prioritize physiologically relevant microenvironments over traditional two-dimensional cultures. This transition necessitates advanced microscopy solutions capable of deep-tissue penetration and long-term volumetric monitoring to accurately capture dynamic cellular interactions within thick biological matrices. The industry is responding with dedicated high-throughput systems designed to support these complex workflows, particularly in oncology and regenerative medicine. Highlighting the scale of this operational expansion, Sartorius reported in its 'Annual Report 2023' in February 2024 that the company generated sales revenue of approximately EUR 3.4 billion, underscoring the strong market uptake for solutions enabling sophisticated cell culture applications.

The emergence of Multi-Omics Integration with Live Cell Data represents a significant leap forward, moving the market beyond morphological observation to comprehensive functional phenotyping. By correlating real-time imaging with spatial transcriptomics and proteomics, scientists can now map the molecular mechanisms driving cellular behavior, a capability that is critical for precision medicine and biomarker discovery. This trend is driving the acquisition of hybrid platforms that combine optical microscopy with spatial profiling technologies. Validating the financial impact of this strategic diversification, Bruker Corporation reported in its 'Fourth Quarter and Full Year 2023 Financial Results' release in February 2024 that full-year revenues reached USD 2.96 billion, driven by its expanding portfolio in spatial biology and cellular analysis.

Key Market Players

  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies Inc.
  • Blue-Ray Biotech Corp.
  • Axion BioSystems, Inc
  • Curiosis Inc.
  • Carl Zeiss AG
  • Thermo Fisher Scientific Inc.
  • Perkin Elmer Inc
  • Danaher Corporation
  • Nikon Corporation

Report Scope

In this report, the Global Live Cell Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Live Cell Imaging Market, By Product

  • Instruments
  • Consumables
  • Software
  • Services

Live Cell Imaging Market, By Application

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery

Live Cell Imaging Market, By Technology

  • Time Lapse Microscopy
  • Fluorescence Recovery After Photo Bleaching
  • High Content Screening
  • Fluorescence Resonance Energy Transfer
  • Others

Live Cell Imaging Market, By End-Users

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organizations

Live Cell Imaging Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Live Cell Imaging Market.

Available Customizations:

Global Live Cell Imaging Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Live Cell Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Instruments, Consumables, Software, Services)
    • 5.2.2. By Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery)
    • 5.2.3. By Technology (Time Lapse Microscopy, Fluorescence Recovery After Photo Bleaching, High Content Screening, Fluorescence Resonance Energy Transfer, Others)
    • 5.2.4. By End-Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations)
    • 5.2.5. By Region
    • 5.2.6. By Company (2025)
  • 5.3. Market Map

6. North America Live Cell Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Technology
    • 6.2.4. By End-Users
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Live Cell Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By End-Users
    • 6.3.2. Canada Live Cell Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By End-Users
    • 6.3.3. Mexico Live Cell Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By End-Users

7. Europe Live Cell Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Technology
    • 7.2.4. By End-Users
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Live Cell Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By End-Users
    • 7.3.2. France Live Cell Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By End-Users
    • 7.3.3. United Kingdom Live Cell Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By End-Users
    • 7.3.4. Italy Live Cell Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By End-Users
    • 7.3.5. Spain Live Cell Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By End-Users

8. Asia Pacific Live Cell Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Technology
    • 8.2.4. By End-Users
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Live Cell Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By End-Users
    • 8.3.2. India Live Cell Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By End-Users
    • 8.3.3. Japan Live Cell Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By End-Users
    • 8.3.4. South Korea Live Cell Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By End-Users
    • 8.3.5. Australia Live Cell Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By End-Users

9. Middle East & Africa Live Cell Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Technology
    • 9.2.4. By End-Users
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Live Cell Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By End-Users
    • 9.3.2. UAE Live Cell Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By End-Users
    • 9.3.3. South Africa Live Cell Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By End-Users

10. South America Live Cell Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Technology
    • 10.2.4. By End-Users
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Live Cell Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By End-Users
    • 10.3.2. Colombia Live Cell Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By End-Users
    • 10.3.3. Argentina Live Cell Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By End-Users

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Live Cell Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Bio-Rad Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Agilent Technologies Inc.
  • 15.3. Blue-Ray Biotech Corp.
  • 15.4. Axion BioSystems, Inc
  • 15.5. Curiosis Inc.
  • 15.6. Carl Zeiss AG
  • 15.7. Thermo Fisher Scientific Inc.
  • 15.8. Perkin Elmer Inc
  • 15.9. Danaher Corporation
  • 15.10. Nikon Corporation

16. Strategic Recommendations

17. About Us & Disclaimer